These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Charcot-Leyden crystal protein (galectin-10) is not a dual function galectin with lysophospholipase activity but binds a lysophospholipase inhibitor in a novel structural fashion. Ackerman SJ, Liu L, Kwatia MA, Savage MP, Leonidas DD, Swaminathan GJ, Acharya KR. J Biol Chem; 2002 Apr 26; 277(17):14859-68. PubMed ID: 11834744 [Abstract] [Full Text] [Related]
23. Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. Ackerman SJ, Corrette SE, Rosenberg HF, Bennett JC, Mastrianni DM, Nicholson-Weller A, Weller PF, Chin DT, Tenen DG. J Immunol; 1993 Jan 15; 150(2):456-68. PubMed ID: 8419478 [Abstract] [Full Text] [Related]
24. Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Weller PF, Bach DS, Austen KF. J Biol Chem; 1984 Dec 25; 259(24):15100-5. PubMed ID: 6511787 [Abstract] [Full Text] [Related]
25. The Charcot-Leyden crystal protein revisited-A lysopalmitoylphospholipase and more. Weller PF, Wang H, Melo RCN. J Leukoc Biol; 2020 Jul 25; 108(1):105-112. PubMed ID: 32272499 [Abstract] [Full Text] [Related]
26. Eosinophilia and elevated serum levels of eosinophil major basic protein and Charcot-Leyden crystal protein (lysophospholipase) after treatment of patients with Bancroft's filariasis. Ackerman SJ, Gleich GJ, Weller PF, Ottesen EA. J Immunol; 1981 Sep 25; 127(3):1093-8. PubMed ID: 7021674 [No Abstract] [Full Text] [Related]
27. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Denburg JA, Telizyn S, Messner H, Lim B, Jamal N, Ackerman SJ, Gleich GJ, Bienenstock J. Blood; 1985 Aug 25; 66(2):312-8. PubMed ID: 2410064 [Abstract] [Full Text] [Related]
28. Ultrastructural immunogold localization of tumor necrosis factor-alpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. Beil WJ, Weller PF, Tzizik DM, Galli SJ, Dvorak AM. J Histochem Cytochem; 1993 Nov 25; 41(11):1611-5. PubMed ID: 8409368 [Abstract] [Full Text] [Related]
29. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Peters MS, Rodriguez M, Gleich GJ. Lab Invest; 1986 Jun 25; 54(6):656-62. PubMed ID: 3520144 [Abstract] [Full Text] [Related]
30. Cellular and subcellular localization of cationic leukocyte antigen (CLA) in human eosinophil granulocytes. Gutierrez-Peña EJ, Tischendorf FW, Brattig NW, Knab J. Arch Med Res; 1997 Jun 25; 28(4):499-505. PubMed ID: 9428573 [Abstract] [Full Text] [Related]
34. FORMATION OF CHARCOT-LEYDEN CRYSTALS IN HUMAN EOSINOPHILS AND BASOPHILS AND STUDY OF THE COMPOSITION OF ISOLATED CRYSTALS. ARCHER GT, BLACKWOOD A. J Exp Med; 1965 Jul 01; 122(1):173-80. PubMed ID: 14325469 [Abstract] [Full Text] [Related]